Your session is about to expire
← Back to Search
Omega-3 Fatty Acid
Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides
N/A
Waitlist Available
Led By Darshan S Kelley, PhD
Research Sponsored by USDA, Western Human Nutrition Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
This trial will investigate if adding DHA to the diets of hyperlipidemic men can reduce risk factors for heart disease, like triglycerides and inflammation.
Eligible Conditions
- High Triglycerides
- Hypertriglyceridemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Martek Biosciences Corporation Neuromins Capsules 7.5 g DHA oil/day
Group II: 2Placebo Group1 Intervention
7.5 g/ day olive oil
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Docosahexenoic acid (DHA)
2003
N/A
~40
Find a Location
Who is running the clinical trial?
USDA, Western Human Nutrition Research CenterLead Sponsor
62 Previous Clinical Trials
19,022 Total Patients Enrolled
VA Northern California Health Care SystemFED
18 Previous Clinical Trials
3,407 Total Patients Enrolled
DSM Nutritional Products, Inc.Industry Sponsor
96 Previous Clinical Trials
57,194 Total Patients Enrolled
Darshan S Kelley, PhDPrincipal InvestigatorUSDA, ARS, WHNRC
1 Previous Clinical Trials
10 Total Patients Enrolled